High Tower Advisors, LLC Eye Point Pharmaceuticals, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 32,690 shares of EYPT stock, worth $394,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,690
Previous 30,690
6.52%
Holding current value
$394,895
Previous $634,000
55.21%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EYPT
# of Institutions
158Shares Held
57.4MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$62.5 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$45.5 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$44.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$43.4 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $412M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...